FBIOP logo

Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock


FBIOP: Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.


Show FBIOP Financials

Consumer Interest
SEC Filings

Recent trades of FBIOP by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by FBIOP's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of FBIOP in WallStreetBets Daily Discussion


Recent insights relating to FBIOP

CNBC Recommendations

Recent picks made for FBIOP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in FBIOP

Corporate Flights

Flights by private jets registered to FBIOP